Filed: 10/28/2022ACC: 0001420506-22-001926
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $295.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$295.6K
Total AUM (reported)
30.84M
Total Shares
Allocation by class
COM$239.1K80.9%
COM NEW$32.5K11.0%
SHS$12.2K4.1%
COMMON STOCK$4.9K1.6%
COM PAR $.01$4.8K1.6%
SPONSORED ADS$1.3K0.4%
SPONSORED ADR$798.000.3%
Portfolio Concentration
Top 3$44.1K14.9%
4–10$70.4K23.8%
11–25$96.9K32.8%
Rest$84.2K28.5%
Top 3 weight
14.9%
Top 10 weight
38.7%
Voting Authority Distribution
Total shares with voting rights: 30.84M
Sole
Full voting authority
30.84M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings75
Rows:
BELLUS HEALTH INC NEW
SOLEShares1.66M
TypeSH
Market value$17.5K
5.91%
Sole
1.66M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares393K
TypeSH
Market value$14.5K
4.92%
Sole
393K
Shared
0.00
None
0.00
PROMETHEUS BIOSCIENCES INC
SOLEShares204.70K
TypeSH
Market value$12.1K
4.09%
Sole
204.70K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares620.46K
TypeSH
Market value$11.1K
3.77%
Sole
620.46K
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares665.85K
TypeSH
Market value$11.1K
3.74%
Sole
665.85K
Shared
0.00
None
0.00
ANAVEX LIFE SCIENCES CORP
SOLEShares1.04M
TypeSH
Market value$10.8K
3.64%
Sole
1.04M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$10.2K
3.46%
Sole
300K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares324.42K
TypeSH
Market value$9.2K
3.11%
Sole
324.42K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares606.61K
TypeSH
Market value$9.1K
3.06%
Sole
606.61K
Shared
0.00
None
0.00
POSEIDA THERAPEUTICS INC
SOLEShares2.55M
TypeSH
Market value$9.0K
3.05%
Sole
2.55M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares245.99K
TypeSH
Market value$8.9K
3.00%
Sole
245.99K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares543.78K
TypeSH
Market value$8.6K
2.90%
Sole
543.78K
Shared
0.00
None
0.00
VIEWRAY INC
SOLEShares2.32M
TypeSH
Market value$8.5K
2.86%
Sole
2.32M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares115K
TypeSH
Market value$7.0K
2.36%
Sole
115K
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares994.07K
TypeSH
Market value$6.7K
2.27%
Sole
994.07K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares32.55K
TypeSH
Market value$6.5K
2.20%
Sole
32.55K
Shared
0.00
None
0.00
VERU INC
SOLEShares550K
TypeSH
Market value$6.3K
2.14%
Sole
550K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares136.13K
TypeSH
Market value$6.3K
2.14%
Sole
136.13K
Shared
0.00
None
0.00
APOLLO ENDOSURGERY INC
SOLEShares1.14M
TypeSH
Market value$6.3K
2.12%
Sole
1.14M
Shared
0.00
None
0.00
MERUS N V
SOLEShares295.14K
TypeSH
Market value$5.9K
2.00%
Sole
295.14K
Shared
0.00
None
0.00
CERUS CORP
SOLEShares1.62M
TypeSH
Market value$5.8K
1.97%
Sole
1.62M
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares983.52K
TypeSH
Market value$5.7K
1.94%
Sole
983.52K
Shared
0.00
None
0.00
CLENE INC
SOLEShares1.73M
TypeSH
Market value$4.9K
1.64%
Sole
1.73M
Shared
0.00
None
0.00
INSMED INC
SOLEShares224.02K
TypeSH
Market value$4.8K
1.63%
Sole
224.02K
Shared
0.00
None
0.00
NKARTA INC
SOLEShares362.38K
TypeSH
Market value$4.8K
1.61%
Sole
362.38K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BELLUS HEALTH INC NEWSOLE | COM NEW | 1.66M | SH | $17.5K 5.91% | 1.66M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 393K | SH | $14.5K 4.92% | 393K | 0.00 | 0.00 |
PROMETHEUS BIOSCIENCES INCSOLE | COM | 204.70K | SH | $12.1K 4.09% | 204.70K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 620.46K | SH | $11.1K 3.77% | 620.46K | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 665.85K | SH | $11.1K 3.74% | 665.85K | 0.00 | 0.00 |
ANAVEX LIFE SCIENCES CORPSOLE | COM NEW | 1.04M | SH | $10.8K 3.64% | 1.04M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 300K | SH | $10.2K 3.46% | 300K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 324.42K | SH | $9.2K 3.11% | 324.42K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 606.61K | SH | $9.1K 3.06% | 606.61K | 0.00 | 0.00 |
POSEIDA THERAPEUTICS INCSOLE | COM | 2.55M | SH | $9.0K 3.05% | 2.55M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 245.99K | SH | $8.9K 3.00% | 245.99K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 543.78K | SH | $8.6K 2.90% | 543.78K | 0.00 | 0.00 |
VIEWRAY INCSOLE | COM | 2.32M | SH | $8.5K 2.86% | 2.32M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 115K | SH | $7.0K 2.36% | 115K | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 994.07K | SH | $6.7K 2.27% | 994.07K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 32.55K | SH | $6.5K 2.20% | 32.55K | 0.00 | 0.00 |
VERU INCSOLE | COM | 550K | SH | $6.3K 2.14% | 550K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 136.13K | SH | $6.3K 2.14% | 136.13K | 0.00 | 0.00 |
APOLLO ENDOSURGERY INCSOLE | COM | 1.14M | SH | $6.3K 2.12% | 1.14M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 295.14K | SH | $5.9K 2.00% | 295.14K | 0.00 | 0.00 |
CERUS CORPSOLE | COM | 1.62M | SH | $5.8K 1.97% | 1.62M | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 983.52K | SH | $5.7K 1.94% | 983.52K | 0.00 | 0.00 |
CLENE INCSOLE | COMMON STOCK | 1.73M | SH | $4.9K 1.64% | 1.73M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 224.02K | SH | $4.8K 1.63% | 224.02K | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 362.38K | SH | $4.8K 1.61% | 362.38K | 0.00 | 0.00 |
Page 1 of 3